1-Year Results of the Hydroxyapatite Polymer-Free Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions. The VESTASYNC I Trial

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 422-427

  Costa Jr , J Ribamar ^a   Abizaid, Alexandre ^a   Costa, Ricardo ^a   Feres, Fausto ^a   Tanajura, Luiz Fernando ^a   Abizaid, Andréa ^a   Maldonado, Galo ^a   Staico, Rodolfo ^a   Siqueira, Dimytri ^a   Sousa, Amanda G M R ^a   Bonan, Raoul ^b   Sousa, J Eduardo ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

intravascular ultrasound; polymer free sirolimus eluting stent; quantitative coronary angiography

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYAPATITE; POLYMER; RAPAMYCIN; STAINLESS STEEL; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; LOW DRUG DOSE; MALE; POROSITY; PRESCRIPTION; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CORONARY ARTERY BYPASS GRAFT; ECHOGRAPHY; INTENSIVE CARE UNIT; MIDDLE AGED; PROSPECTIVE STUDY; RESTENOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; DURAPATITE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POLYMERS; PROSPECTIVE STUDIES; SIROLIMUS; TICLOPIDINE; TIME FACTORS; ANGIOPLASTY, BALLOON, CORONARY;

EID: 65549135905     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.02.009     Document Type: Article

References (14)

1. Morice M.C., Serruys P.W., Sousa J.E., et al., RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Stettler C., Allemann S., Wandel S., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 337 (2008) a1331
4. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
5. Notaristefano S., Sbarzaglia P., and Cavallini C. Late stent thrombosis after drug-eluting stent implantation: epidemiological, clinical and pathophysiological aspects. G Ital Cardiol (Rome) 9 (2008) 674-683
6. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
7. Siqueira D.A., Abizaid A.A., Costa J.R., et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J 28 (2007) 1304-1309
8. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
9. Lüscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
10. Costa Jr. J.R., Abizaid A., Costa R.A., et al. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions: a first-in-human analysis of a third-generation drug-eluting stent system. J Am Coll Cardiol Intv 1 (2008) 545-551
11. Mehilli J., Byrne R.A., Wieczorek A., et al. Intracoronary Stenting and Angiographic Restenosis Investigators-Test Efficacy of Rapamycin-Eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3). Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 29 (2008) 1975-1982
12. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
13. Lim S.Y., Jeong M.H., Hong S.J., et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. Circ J 72 (2008) 463-468
14. Meredith I., Ormiston J., Whitbourn R., et al., ENDEAVOR Investigators. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: ENDEAVOR I trial. Eurointervention 2 (2005) 157-164